<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Acetaminophen with Codeine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Acetaminophen with Codeine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Analgesia / Anti-inflammatory</div>
      <h1>Acetaminophen with Codeine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Acetaminophen with Codeine Tablets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Moderate to moderately severe pain (short-term use)</strong>
            <ul>
              <li>Typical formulation: Acetaminophen 300 mg / Codeine 30 mg (Tylenol #3 equivalent)</li>
              <li>1–2 tablets PO every 4–6 hours as needed for pain</li>
              <li>Maximum: 12 tablets/24 hours (to limit acetaminophen to 3600 mg/day and codeine exposure)</li>
            </ul>
          </li>
          <li><strong>Lower strength formulation (if stocked)</strong>
            <ul>
              <li>Acetaminophen 300 mg / Codeine 15 mg: 1–2 tablets every 4–6 hours as needed</li>
            </ul>
          </li>
          <li><strong>Important considerations</strong>
            <ul>
              <li>Use lowest effective dose for shortest duration</li>
              <li>Limit total acetaminophen from all sources to &lt;4000 mg/day (lower in liver disease, chronic alcohol use)</li>
              <li>Codeine is a prodrug requiring CYP2D6 metabolism; ~10% of population are poor metabolizers (reduced effect) and ~1–2% ultra-rapid metabolizers (increased toxicity risk)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Moderate to moderately severe acute pain unresponsive to non-opioid analgesics alone</li>
          <li>Short-term pain management when NSAIDs are contraindicated or inadequate</li>
          <li>Dental pain, musculoskeletal pain, post-procedural pain (when appropriate)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Codeine hypersensitivity or severe respiratory depression/significant respiratory compromise</li>
          <li>Acute or severe asthma in unmonitored setting</li>
          <li>Known or suspected paralytic ileus or GI obstruction</li>
          <li>Concurrent MAO inhibitor use (or within 14 days)</li>
          <li>Children &lt;12 years (codeine risk); avoid in adolescents post-tonsillectomy/adenoidectomy</li>
          <li>Pregnancy/breastfeeding: codeine crosses placenta and enters breast milk; avoid or use with extreme caution (neonatal respiratory depression risk)</li>
          <li>Severe hepatic impairment (acetaminophen toxicity risk); dose adjustment in renal impairment</li>
          <li>Avoid alcohol and CNS depressants (additive sedation/respiratory depression)</li>
          <li>CYP2D6 ultra-rapid metabolizers: increased risk of opioid toxicity</li>
          <li>Substance use disorder history: use cautiously with close monitoring</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Drowsiness, sedation, dizziness, lightheadedness</li>
          <li>Nausea, vomiting, constipation</li>
          <li>Respiratory depression (dose-dependent; risk with overdose or susceptible patients)</li>
          <li>Pruritus, sweating</li>
          <li>Potential for tolerance, dependence, and misuse with prolonged use</li>
          <li>Acetaminophen: hepatotoxicity with overdose or chronic excessive use</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>May take with food or milk to reduce GI upset</li>
          <li>Do not exceed recommended dose or frequency</li>
          <li>Avoid concurrent acetaminophen-containing products (cold/flu medications, other analgesics)</li>
          <li>Counsel on constipation risk: encourage hydration, fiber, activity; consider stool softener if prolonged use</li>
          <li>Warn about sedation and impaired performance: avoid watchkeeping, machinery, driving until response known</li>
          <li>Counsel: do not share medication; store securely</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Pain relief and functional improvement (reassess need frequently)</li>
          <li>Sedation/CNS depression, respiratory rate (especially first dose and dose escalation)</li>
          <li>Constipation and other GI effects</li>
          <li>Signs of misuse, diversion, or dependence if available longer-term</li>
          <li>Reassess indication daily; transition to non-opioid analgesia as soon as feasible</li>
          <li>Total acetaminophen intake from all sources</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Opioid stewardship: prescribe only when clearly indicated; use shortest effective course (typically ≤3 days for acute pain)</li>
          <li>Operational impact: codeine causes sedation—ensure patient is not assigned to critical duties while taking; document fitness restrictions</li>
          <li>Limited monitoring capability: be conservative in higher-risk patients (elderly, respiratory disease, renal/hepatic impairment)</li>
          <li>Secure storage: treat as controlled substance; maintain accountability/documentation</li>
          <li>If prolonged use becomes necessary, plan for taper and evac/consultation to avoid withdrawal</li>
          <li>Reassess non-opioid alternatives and non-pharmacologic approaches regularly</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (acetaminophen with codeine): <a href="https://pdf.hres.ca/dpd_pm/00068450.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00068450.PDF</a></li>
          <li>Health Canada product monograph (Tylenol with Codeine): <a href="https://pdf.hres.ca/dpd_pm/00043018.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00043018.PDF</a></li>
          <li>Canadian Guideline for Opioids for Chronic Non-Cancer Pain: <a href="https://nationalpaincentre.mcmaster.ca/opioid-guideline/" target="_blank" rel="noopener">https://nationalpaincentre.mcmaster.ca/opioid-guideline/</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
